Global Aspergillosis Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: July 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Aspergillosis Market was valued at $4.3 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 4.8% CAGR, to an estimated market size of $5.5 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global aspergillosis market includes the diagnosis, treatment, and management of fungal infections caused by the Aspergillus mold. The scope covers therapeutic interventions such as antifungal medications (azoles, polyenes, and echinocandins) and corticosteroids, as well as diagnostic tools used to identify conditions like Invasive Aspergillosis (IA), Chronic Pulmonary Aspergillosis (CPA), and Allergic Bronchopulmonary Aspergillosis (ABPA).
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Aspergillosis Market in the period 2025-30:
- The rising immunocompromised population, particularly organ transplant and cancer patients, remains the primary driver for invasive infection treatments.
- Technological advancements in diagnostics, such as PCR and NGS, are enabling earlier detection and more targeted therapeutic interventions.
- The emergence of azole-resistant Aspergillus strains is pushing research and development toward novel antifungal drug classes and combination therapies.
- Post-viral complications, specifically COVID-19-associated pulmonary aspergillosis (CAPA), have increased clinical focus and demand for antifungal protocols.
- Increasing global prevalence of asthma and COPD is significantly expanding the patient pool for allergic and chronic forms of the disease.
- A shift toward personalized medicine is driving the customization of treatment schedules to improve efficacy and reduce potential drug toxicity.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Invasive Aspergillosis
- Allergic Bronchopulmonary Aspergillosis
- Chronic Pulmonary Aspergillosis & Others